Holden Comprehensive Cancer Center is a clinical research site located in Iowa City, Iowa, United States 52242-1009.
Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.
Holden Comprehensive Cancer Center has participated in 70 clinical trials with 7 currently active.
Therapeutic areas: Sarcoma, Uterine Cervical Neoplasms, Endometrial Neoplasms.
Sponsors: Gynecologic Oncology Group, John M. Buatti, National Cancer Institute (NCI).
Trust Score: 88/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Holden Comprehensive Cancer Center has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Holden Comprehensive Cancer Center has 70 clinical trials on record, with 7 currently active. Their work covers Sarcoma, Uterine Cervical Neoplasms, Endometrial Neoplasms.
Yes — Holden Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.